Hyperparathyroidism

• FDA approval · 2013-07-22
  FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)

  The FDA approved a supplemental application for Zemplar (paricalcitol) from AbbVie Inc.

• FDA approval · 2013-05-24
  FDA Approved: CALCITRIOL — Original Application (BIONPHARMA INC.)

  FDA approved the original ANDA application for Calcitriol from BIONPHARMA INC., a generic version of the active vitamin D3 analog.

• FDA approval · 2013-05-15
  FDA Approved: CALCITRIOL — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  The FDA approved a supplemental application for CALCITRIOL (calcitriol) from Sun Pharmaceutical Industries, Inc., updating the product’s reg…

• FDA approval · 2012-06-28
  FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)

  FDA approved the supplemental application for Zemplar (paricalcitol) from AbbVie Inc.

• FDA approval · 2011-08-01
  FDA Approved: SENSIPAR — Supplemental Application (Amgen Inc)

  The FDA approves a supplemental application for Sensipar (cinacalcet hydrochloride) submitted by Amgen Inc.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2011-04-06
  FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)

  The FDA approved a supplemental application for Zemplar (paricalcitol) filed by AbbVie Inc., approving an update to the product labeling.

• FDA approval · 2011-02-01
  FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)

  The FDA approved a supplemental application for Zemplar (paricalcitol) submitted by AbbVie.

• FDA approval · 2010-06-11
  FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)

  The FDA approved a supplemental application for ZEMPLAR (paricalcitol) from AbbVie Inc.

• FDA approval · 2009-11-12
  FDA Approved: SENSIPAR — Supplemental Application (Amgen Inc)

  The FDA approved Amgen's supplemental application for SENSIPAR (cinacalcet hydrochloride), resulting in updated labeling for the product.

• FDA approval · 2009-08-20
  FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)

  FDA approves a supplemental application for ZEMPLAR (paricalcitol) submitted by AbbVie.

• FDA approval · 2009-06-29
  FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)

  FDA approved a supplemental application for ZEMPLAR (paricalcitol) by AbbVie Inc.

• FDA approval · 2008-12-19
  FDA Approved: SENSIPAR — Supplemental Application (Amgen Inc)

  FDA approves a supplemental NDA for SENSIPAR (cinacalcet hydrochloride) submitted by Amgen, resulting in updated labeling and potential new/…

• FDA approval · 2008-02-28
  FDA Approved: SENSIPAR — Supplemental Application (Amgen Inc)

  The FDA approved a supplemental application for SENSIPAR (cinacalcet hydrochloride) from Amgen.

• FDA approval · 2006-07-03
  FDA Approved: CALCITRIOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  The FDA approved a supplemental application for Calcitriol from Hikma Pharmaceuticals USA Inc., updating the approval status for this generi…